Immix Biopharma (IMMX)
(Delayed Data from NSDQ)
$1.81 USD
-0.04 (-2.16%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $1.81 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, Immix Biopharma (IMMX) reported earnings of -$0.15 per share, beating the Zacks Consensus Estimate of $-0.21 per share. This reflects a positive earnings surprise of 28.57%. Look out for IMMX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 30.43%.
Earnings History
Price & Consensus
Zacks News for IMMX
What Makes Immix Biopharma, Inc. (IMMX) a Good Fit for 'Trend Investing'
IMMX: What are Zacks experts saying now?
Zacks Private Portfolio Services